Studies have demonstrated that mRNA levels of RIPK1 and MLKL are significantly elevated in AD patients, correlating positively with Braak staging, while RIPK3 levels show an inverse correlation (Braak and Braak, 1995). Here, RIPK3 is linked to Alzheimer disease.